
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd is advancing its commercial reach through strategic distribution agreements with Imperial Imaging Technology and Digital X-Ray Imaging, enhancing access to its Nanox.ARC system in key Southeast states and Arkansas, respectively, thereby improving its point-of-care imaging model. The company focuses on increasing revenue through its three segments, particularly Radiology Services, and emphasizes the importance of scaling its installed base to validate its commercial model and drive revenue growth. Recent regulatory achievements, including FDA 510(k) clearance for TAP2D, showcase the company's commitment to innovation and support its long-term growth potential in the medical imaging sector.
Bears say
The financial outlook for Nano X Imaging Ltd appears negative primarily due to prolonged development and commercialization timelines that have necessitated greater investment than previously expected. This extended timeframe may hinder the company's ability to generate revenue, particularly as key income is derived from the Radiology Services segment. Additionally, the reduction of the price target from $8.0 to $5.0 reflects a recalibration of expectations regarding the company's financial performance and market execution.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares